Vancomycin Hydrochloride for Injection
Presence of Particulate Matter: Glass particulate matter detected in injectable.
1,018 recalls, newest first
Presence of Particulate Matter: Glass particulate matter detected in injectable.
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Failed Impurities/Degradations Specifications
Failed Impurities/Degradation specifications
Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
cGMP Deviations
cGMP Deviations
cGMP Deviations
cGMP Deviations
cGMP Deviations
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
cGMP Deviations
cGMP Deviations
cGMP Deviations
cGMP Deviations
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back